San Diego, CA -- (SBWIRE) -- 11/01/2013 -- Buka Ventures Inc (OTCBB:NNRX) reported that it has entered into a non-binding Letter of Intent with Genesar Nutraceuticals, LLC with the intention of completing a licencing agreement for the marketing and distribution of GenEpic™.
GenEpic™ has been developed by Buka Ventures Inc. It is currently undergoing FDA approved human clinical studies. CEO of the company, Dr. Tracy K. Gibbs stated that GenEpic™ is an exciting and very promising natural treatment for prostate cancer that does not consist of chemotherapy or radiation. It focuses on adenosine-triphosphate (ATP) inhibition in cells.
Tracy K. Gibbs continued that for the past few weeks, the company has been discussing the potential acquisition of the exclusive distribution rights to GenEpic™ and it is pleased that Genesar now wants to move forward to put together a formal licencing agreement.
To see what SuperSmartStocks reflects about Buka Ventures Inc for both short term and long term please click here: NNRX
SuperSmartStocks is all about super stock stars, scouring the markets for parabolic stocks that make epic moves and win colossal gains for investors. Penny Stocks are playing real big moves; SSS catches and reports investors all about gigantic leaps and makes losers the winners! To find out for the latest winning stocks, come and visit the SuperSmartStocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: SuperSmartStocks.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://SuperSmartStocks.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold SuperSmartStocks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SuperSmartStocks.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SuperSmartStocks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SuperSmartStocks.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. StockSmartStocks.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)